© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Arcadia Biosciences, Inc. (RKDA) shows an Average True Range (ATR) of 0.28 and an Enterprise Value of -2.7M. Its average trading volume over the past 3 months is 479.05K, indicating liquidity. These fundamental metrics provide insight into RKDA's underlying financial health and market activity.
Arcadia Biosciences, Inc. (RKDA) technical indicators as of December 30, 2025: the SMA 20 is -37.23%, SMA 50 at -40.54%, and SMA 200 at -43.4%. The RSI 14 value is 18.56, suggesting its current momentum. These technical analysis signals help assess RKDA's price trends and potential future movements.
Arcadia Biosciences, Inc. (RKDA) stock performance overview as of December 30, 2025: The 52-week high is $6.71 (currently -67.21% below), and the 52-week low is $2.17 (currently -13.05% above). Over the past year, RKDA's performance is N/A, compared to the S&P 500's 10.62% change.
According to market data, Arcadia Biosciences, Inc. (RKDA) stock's recent performance metrics show that over the last month, RKDA is -38.55%, with a Year-to-Date (YTD) performance of -62.84%. Over the past year, the stock has seen a N/A change. These figures summarize RKDA's price movements across various periods, reflecting its historical returns.
According to current financial data, RKDA stock's P/E (TTM) ratio is -0.47, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 6.66. Key valuation ratios for RKDA, including P/S (0.66), P/B (0.78), and P/FCF (-0.47), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.